Regulation of metastasis by microRNAs in ovarian cancer

Frontiers in Oncology

Volumn 4 JUN, Issue , 2014, Pages

  Wang, Yongchao ^a   Kim, Sangmi ^a   Kim, Il man ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Angiogenesis; Cancer stem cells; Epithelial mesenchymal transition; Extracellular matrix; miRs; Ovarian cancer

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 1; CD133 ANTIGEN; CD24 ANTIGEN; CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FOLLITROPIN; HERMES ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MICRORNA; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR SOX4; TRANSCRIPTION FACTOR ZEB1; UNCLASSIFIED DRUG; UVOMORULIN; VASCULOTROPIN RECEPTOR; VIMENTIN;

ANGIOGENESIS; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER STEM CELL; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL TRANSFORMATION; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HUMAN; METASTASIS; NONHUMAN; OVARIAN CANCER CELL LINE; OVARY CANCER; PHENOTYPE; SHORT SURVEY;

EID: 84904612549     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2014.00143     Document Type: Short Survey

References (46)

1. Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin (2012) 62(4):220-41. doi:10.3322/caac.21149
2. Nossov V, Amneus M, Su F, Lang J, Janco JM, Reddy ST, et al. The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125? Am J Obstet Gynecol (2008) 199(3):215-23. doi:10.1016/j.ajog.2008.04.009
3. Bast RC Jr, Xu FJ, Yu YH, Barnhill S, Zhang Z, Mills GB. CA 125: the past and the future. Int J Biol Markers (1998) 13(4):179-87.
4. Bagan P, Berna P, Assouad J, Hupertan V, Le Pimpec Barthes F, Riquet M. Value of cancer antigen 125 for diagnosis of pleural endometriosis in females with recurrent pneumothorax. Eur Respir J (2008) 31(1):140-2. doi:10.1183/09031936.00094206
5. Sarandakou A, Protonotariou E, Rizos D. Tumor markers in biological fluids associated with pregnancy. Crit Rev Clin Lab Sci (2007) 44(2):151-78. doi:10.1080/10408360601003143
6. Asher V, Hammond R, Duncan TJ. Pelvic mass associated with raised CA 125 for benign condition: a case report. World J Surg Oncol (2010) 8:28. doi:10.1186/1477-7819-8-28
7. Chen D, Zhang Y, Wang J, Chen J, Yang C, Cai K, et al. microRNA-200c overexpression inhibits tumorigenicity and metastasis of CD117+CD44+ ovarian cancer stem cells by regulating epithelial-mesenchymal transition. J Ovarian Res (2013) 6(1):50. doi:10.1186/1757-2215-6-50
8. Wu Q, Guo R, Lin M, Zhou B, Wang Y. microRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2. Gynecol Oncol (2011) 122(1):149-54. doi:10.1016/j.ygyno.2011.03.026
9. Park YT, Jeong JY, Lee MJ, Kim KI, Kim TH, Kwon YD, et al. microRNAs overexpressed in ovarian ALDH1-positive cells are associated with chemoresistance. J Ovarian Res (2013) 6(1):18. doi:10.1186/1757-2215-6-18
10. Xu CX, Xu M, Tan L, Yang H, Permuth-Wey J, Kruk PA, et al. microRNA miR-214 regulates ovarian cancer cell stemness by targeting p53/Nanog. J Biol Chem (2012) 287(42):34970-8. doi:10.1074/jbc.M112.374611
11. Cheng W, Liu T, Wan X, Gao Y, Wang H. microRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells. FEBS J (2012) 279(11):2047-59. doi:10.1111/j.1742-4658.2012.08589.x
12. Wang Z, Ting Z, Li Y, Chen G, Lu Y, Hao X. microRNA-199a is able to reverse cisplatin resistance in human ovarian cancer cells through the inhibition of mammalian target of rapamycin. Oncol Lett (2013) 6(3):789-94. doi:10.3892/ol.2013.1448
13. Cowden Dahl KD, Dahl R, Kruichak JN, Hudson LG. The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells. Neoplasia (2009) 11(11):1208-15. doi:10.1593/neo.09942
14. Yeh YM, Chuang CM, Chao KC, Wang LH. microRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1alpha. Int J Cancer (2013) 133(4):867-78. doi:10.1002/ijc.28086
15. Jabbari N, Reavis AN, McDonald JF. Sequence variation among members of the miR-200 microRNA family is correlated with variation in the ability to induce hallmarks of mesenchymal-epithelial transition in ovarian cancer cells. J Ovarian Res (2014) 7(1):12. doi:10.1186/1757-2215-7-12
16. Clevers H. The cancer stem cell: premises, promises and challenges. Nat Med (2011) 17(3):313-9. doi:10.1038/nm.2304
17. Baccelli I, Trumpp A. The evolving concept of cancer and metastasis stem cells. J Cell Biol (2012) 198(3):281-93. doi:10.1083/jcb.201202014
18. Bapat SA, Mali AM, Koppikar CB, Kurrey NK. Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res (2005) 65(8):3025-9. doi:10.1158/0008-5472.CAN-04-3931
19. Lai Y, Zhang X, Zhang Z, Shu Y, Luo X, Yang Y, et al. The microRNA-27a: ZBTB10-specificity protein pathway is involved in follicle stimulating hormone-induced VEGF, Cox2 and survivin expression in ovarian epithelial cancer cells. Int J Oncol (2013) 42(2):776-84. doi:10.3892/ijo.2012.1743
20. He J, Jing Y, Li W, Qian X, Xu Q, Li FS, et al. Roles and mechanism of miR-199a and miR-125b in tumor angiogenesis. PLoS One (2013) 8(2):e56647. doi:10.1371/journal.pone.0056647
21. Luo X, Dong Z, Chen Y, Yang L, Lai D. Enrichment of ovarian cancer stem-like cells is associated with epithelial to mesenchymal transition through an miRNA-activated AKT pathway. Cell Prolif (2013) 46(4):436-46. doi:10.1111/cpr.12038
22. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell (2007) 26(5):745-52. doi:10.1016/j.molcel.2007.05.010
23. Corney DC, Hwang CI, Matoso A, Vogt M, Flesken-Nikitin A, Godwin AK, et al. Frequent downregulation of miR-34 family in human ovarian cancers. Clin Cancer Res (2010) 16(4):1119-28. doi:10.1158/1078-0432.CCR-09-2642
24. Sorrentino A, Liu CG, Addario A, Peschle C, Scambia G, Ferlini C. Role of microRNAs in drug-resistant ovarian cancer cells. Gynecol Oncol (2008) 111(3):478-86. doi:10.1016/j.ygyno.2008.08.017
25. Li J, Liang S, Yu H, Zhang J, Ma D, Lu X. An inhibitory effect of miR-22 on cell migration and invasion in ovarian cancer. Gynecol Oncol (2010) 119(3):543-8. doi:10.1016/j.ygyno.2010.08.034
26. Vang S, Wu HT, Fischer A, Miller DH, MacLaughlan S, Douglass E, et al. Identification of ovarian cancer metastatic miRNAs. PLoS One (2013) 8(3):e58226. doi:10.1371/journal.pone.0058226
27. Liu Z, Liu J, Segura MF, Shao C, Lee P, Gong Y, et al. miR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma. J Pathol (2012) 228(2):204-15. doi:10.1002/path.4000
28. Zhang H, Wang Q, Zhao Q, Di W. miR-124 inhibits the migration and invasion of ovarian cancer cells by targeting SphK1. J Ovarian Res (2013) 6(1):84. doi:10.1186/1757-2215-6-84
29. Xu Q, Liu LZ, Qian X, Chen Q, Jiang Y, Li D, et al. miR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis. Nucleic Acids Res (2012) 40(2):761-74. doi:10.1093/nar/gkr730
30. Vecchione A, Belletti B, Lovat F, Volinia S, Chiappetta G, Giglio S, et al. A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis. Proc Natl Acad Sci U S A (2013) 110(24):9845-50. doi:10.1073/pnas.1305472110
31. Orend G, Chiquet-Ehrismann R. Tenascin-C induced signaling in cancer. Cancer Lett (2006) 244(2):143-63. doi:10.1016/j.canlet.2006.02.017
32. Sengupta S, den Boon JA, Chen IH, Newton MA, Stanhope SA, Cheng YJ, et al. microRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc Natl Acad Sci U S A (2008) 105(15):5874-8. doi:10.1073/pnas.0801130105
33. Negrini M, Calin GA. Breast cancer metastasis: a microRNA story. Breast Cancer Res (2008) 10(2):203. doi:10.1186/bcr1867
34. Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, Linsley PS, et al. microRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol (2008) 28(17):5369-80. doi:10.1128/MCB.00479-08
35. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. microRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology (2007) 133(2):647-58. doi:10.1053/j.gastro.2007.05.022
36. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD, et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature (2008) 451(7175):147-52. doi:10.1038/nature06487
37. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol (2008) 141(5):672-5. doi:10.1111/j.1365-2141.2008.07077.x
38. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A (2008) 105(30):10513-8. doi:10.1073/pnas.0804549105
39. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res (2008) 18(10):997-1006. doi:10.1038/cr.2008.282
40. Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM, Cohn DE. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol (2009) 112(1):55-9. doi:10.1016/j.ygyno.2008.08.036
41. Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y, et al. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol (2010) 28(10):1721-6. doi:10.1200/JCO.2009.24.9342
42. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol (2007) 9(6):654-9. doi:10.1038/ncb1596
43. Rabinowits G, Gercel-Taylor C, Day JM, Taylor DD, Kloecker GH. Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer (2009) 10(1):42-6. doi:10.3816/CLC.2009.n.006
44. Taylor DD, Gercel-Taylor C. microRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol (2008) 110(1):13-21. doi:10.1016/j.ygyno.2008.04.033
45. Kroh EM, Parkin RK, Mitchell PS, Tewari M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods (2010) 50(4):298-301. doi:10.1016/j.ymeth.2010.01.032
46. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature (2007) 449(7163):682-8. doi:10.1038/nature06174